SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...
Led by a team of Cornell faculty, the Northeast Regional Center for Excellence in Vector-Borne Diseases received a five-year, $8.7 million grant from the Centers for Disease Control and Prevention in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results